|

ASP5541 Clinical Trials

2 actively recruiting trials across 1 location

Also known as: PRL-02

Pipeline

Phase 1: 1Phase 2: 1

Top Sponsors

  • Astellas Pharma Global Development, Inc.2

Indications

  • Metastatic Hormone-sensitive Prostate Cancer2
  • Metastatic Castration-resistant Prostate Cancer2
  • Prostate Cancer2
  • Cancer2

Other1 trial

A Study to Evaluate the Safety and Drug Levels of ASP5541 in Chinese Participants With Prostate Cancer
Phase 1

Tampa, Florida1 trial

A Phase 2 Study to Evaluate the Effects of ASP5541 in Participants With Prostate Cancer

H. Lee Moffitt Cancer Center

Phase 2

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.